Skip to main content

Want a detailed portfolio tracker?

Acasti Pharma (GRCE) P/E (2024 - 2026)

Acasti Pharma (GRCE) P/E from Oct 8, 2024 to Jul 21, 2026. The TTM Acasti Pharma (GRCE) P/E is -4.56. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Acasti Pharma (GRCE)

YearP/EChange
2026-4.56-45.64%
2025-8.40+188.31%
2024-2.91N/A

Comparison Acasti Pharma (GRCE) P/E with competitors

Acasti Pharma (GRCE) P/E is -4.56.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.09%
ENLVEnlivex Ltd0.07-101.64%
FGENFibroGen Inc0.24-105.26%
CHRSCoherus Biosciences Inc0.85-118.59%
FBIOFortress Biotech Inc0.95-120.79%
ORMPOramed Pharmaceuticals Inc1.50-132.93%
AGENAgenus Inc3.01-165.94%
INVAInnoviva Inc3.15-169.10%
VXRTVaxart Inc3.55-177.77%
CRMDCorMedix Inc3.63-179.50%
CVACCureVac N.V.4.45-197.40%
GLPGGalapagos NV4.86-206.46%
SRPTSarepta Therapeutics Inc4.88-206.97%
ABEOAbeona Therapeutics Inc5.39-218.04%
ABUSArbutus Biopharma Corp5.60-222.60%
ZVRAZevra Therapeutics Inc5.89-228.99%
SPROSpero Therapeutics Inc6.23-236.46%
CGENCompugen Ltd6.31-238.34%
RIGLRigel Pharmaceuticals6.87-250.57%
SLXNSilexion Therapeutics Corp7.30-259.86%
OMEROmeros Corporation9.26-302.86%
AUPHAurinia Pharmaceuticals Inc9.58-310.00%
PLXProtalix BioTherapeutics Inc10.89-338.62%
ACADAcadia Pharmaceuticals Inc11.73-356.97%
TBPHTheravance Biopharma Inc12.26-368.66%
ADMAAdma Biologics Inc12.42-372.08%
HRMYHarmony Biosciences Holdings Inc13.82-402.80%
SABSSAB Biotherapeutics Inc14.14-409.72%
NAGENiagen Bioscience Inc14.82-424.66%
INCYIncyte Corp15.82-446.67%
REGNRegeneron Pharmaceuticals Inc15.86-447.42%
PBYIPuma Biotechnology Inc17.32-479.39%
CPRXCatalyst Pharmaceuticals Inc17.44-482.09%
EXELExelixis Inc17.54-484.26%
TGTXTG Therapeutics Inc18.97-515.54%
MDXGMimedx Group Inc20.55-550.30%
XOMAXOMA Royalty Corp22.87-601.20%
ARGXArgen X SE24.30-632.38%
CTMXCytomX Therapeutics Inc24.82-643.84%
XOMAOXOMA Royalty Corp25.34-655.32%
HALOHalozyme Therapeutics Inc25.62-661.43%
XOMAPXOMA Royalty Corp25.67-662.44%
VRTXVertex Pharmaceuticals Inc27.99-713.38%
RPRXRoyalty Pharma plc - Class A28.69-728.56%
SLNOSoleno Therapeutics Inc29.02-735.74%
ASNDAscendis Pharma A/S30.09-759.19%
LGNDLigand Pharmaceuticals Inc - Class B37.91-930.67%
APLSApellis Pharmaceuticals Inc39.02-954.97%
BMRNBiomarin Pharmaceutical Inc42.21-1024.88%
KRYSKrystal Biotech Inc45.34-1093.50%
ONCBeiGene Ltd69.54-1623.67%
PHARPharming Group N.V.75.03-1743.85%
TECHBio-Techne Corp101.96-2333.96%
VCELVericel Corp109.92-2508.43%
ALNYAlnylam Pharmaceuticals Inc117.96-2684.67%
GMABGenmab140.29-3173.84%
TLXTelix Pharmaceuticals Ltd162.15-3652.85%
CORTCorcept Therapeutics Inc212.86-4763.81%